Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Nickelsen

Showing results (11-20 of 13) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 13 results.
American Journal of Obstetrics and Gynecology|August 6, 2004
Raloxifene is not associated with biologically relevant changes in hot flushes in postmenopausal women for whom therapy is appropriateSantiago Palacios, Maria Lucia F Farias, Horst Luebbert, et al.
Obstetrics and Gynecology|May 4, 2004
Uterine effects of estrogen plus progestin therapy and raloxifene: adjudicated results from the EURALOX studyPatrick Neven, Deborah Quail, Marc Lévrier, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|December 4, 2008
Sequential treatment of severe postmenopausal osteoporosis after teriparatide: final results of the randomized, controlled European Study of Forsteo (EUROFORS)Richard Eastell, Thomas Nickelsen, Fernando Marin, et al.
Pageof 2

Showing results (11-20 of 13) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 13 results.
American Journal of Obstetrics and Gynecology|August 6, 2004
Raloxifene is not associated with biologically relevant changes in hot flushes in postmenopausal women for whom therapy is appropriateSantiago Palacios, Maria Lucia F Farias, Horst Luebbert, et al.
Obstetrics and Gynecology|May 4, 2004
Uterine effects of estrogen plus progestin therapy and raloxifene: adjudicated results from the EURALOX studyPatrick Neven, Deborah Quail, Marc Lévrier, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|December 4, 2008
Sequential treatment of severe postmenopausal osteoporosis after teriparatide: final results of the randomized, controlled European Study of Forsteo (EUROFORS)Richard Eastell, Thomas Nickelsen, Fernando Marin, et al.
Pageof 2